Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 58
Filter
Add more filters

Country/Region as subject
Affiliation country
Publication year range
1.
Int J Mol Sci ; 25(2)2024 Jan 18.
Article in English | MEDLINE | ID: mdl-38256249

ABSTRACT

The acute phase protein Serum Amyloid A (SAA) is synthesised by the liver in response to inflammatory stimuli. Previous studies have revealed that SAA may be a better biomarker of disease activity in inflammatory bowel disease (IBD) compared to C-reactive protein (CRP). This retrospective monocentric study evaluated whether SAA correlates with biomarkers like faecal calprotectin (FC), CRP, the Neutrophil to Lymphocyte ratio (NLR), the platelet count and clinical disease activity of IBD patients. Serum samples from the IBD outpatient clinic of the University Hospital Heidelberg were analysed for SAA concentrations if an FC concentration measurement was available from ±14 days to collection of the serum sample. Three hundred and six serum samples from 265 patients (166 with Crohn's disease, 91 with ulcerative colitis and 8 with IBD unclassified) met the inclusion criteria. There was a significant positive correlation between SAA and FC, CRP, NLR, platelet count and the Simple Clinical Colitis Activity Index (SCCAI). The cut-off for SAA serum concentration at 4.55 mg/L achieved a sensitivity of 57.5% and a specificity of 69.7% for the detection of active inflammation in IBD. SAA may be used as an additional biomarker in the disease monitoring strategy of IBD patients, especially in patients with low CRP concentrations.


Subject(s)
C-Reactive Protein , Inflammatory Bowel Diseases , Humans , Serum Amyloid A Protein , Retrospective Studies , Biomarkers , Inflammatory Bowel Diseases/diagnosis , Leukocyte L1 Antigen Complex
2.
J Inherit Metab Dis ; 46(6): 1078-1088, 2023 11.
Article in English | MEDLINE | ID: mdl-37603032

ABSTRACT

There is a clinical need for early detection of chronic kidney disease (CKD) in patients with organic acidurias. We measured kidney markers in a longitudinal study over 5 years in 40 patients with methylmalonic aciduria (Mut0 ), propionic aciduria (PA), cobalamin A (CblA), and cobalamin C (CblC) deficiencies. Neutrophil gelatinase-associated lipocalin (NGAL), calprotectin (CLP), kidney injury molecule-1 (KIM-1), dickkopf-3 (DKK-3), albumin and beta-2-microglobulin (B2MG) in urine, as well as cystatin C (CysC) in serum were quantified. In Mut0 patients, mean concentrations of B2MG, KIM-1, and DKK-3 were elevated compared with healthy controls, all markers indicative of proximal tubule damage. In PA patients, mean B2MG, albumin, and CLP were elevated, indicating signs of proximal tubule and glomerulus damage and inflammation. In CblC patients, mean B2MG, NGAL, and CLP were increased, and considered as markers for proximal and distal tubule damage and inflammation. B2MG, was elevated in all three diseases, and correlated with DKK-3 in Mut0 /CblA and with eGFR(CysC) and KIM-1 in PA patients, respectively. None of the markers were elevated in CblA patients. Significant deterioration of kidney function, as determined by steady increase in CysC concentrations was noted in seven patients within the observation period. None of the investigated biomarker profiles showed a clear increase or added value for early detection. In conclusion, we identified disease-specific biomarker profiles for inflammation, tubular, and proximal damage in the urine of Mut0 , PA, and CblC patients. Whether these biomarkers can be used for early detection of CKD requires further investigation, as significant kidney function deterioration was observed in only a few patients.


Subject(s)
Renal Insufficiency, Chronic , Humans , Lipocalin-2/urine , Longitudinal Studies , Biomarkers/urine , Renal Insufficiency, Chronic/diagnosis , Kidney , Vitamin B 12 , Amino Acids, Branched-Chain , Inflammation , Albumins
3.
Clin Chem Lab Med ; 61(3): 452-463, 2023 02 23.
Article in English | MEDLINE | ID: mdl-36537103

ABSTRACT

OBJECTIVES: Conventionally, reference intervals are established by direct methods, which require a well-characterized, obviously healthy study population. This elaborate approach is time consuming, costly and has rarely been applied to steroid hormones measured by mass spectrometry. In this feasibility study, we investigate whether indirect methods based on routine laboratory results can be used to verify reference intervals from external sources. METHODS: A total of 11,259 serum samples were used to quantify 13 steroid hormones by mass spectrometry. For indirect estimation of reference intervals, we applied a "modified Hoffmann approach", and verified the results with a more sophisticated statistical method (refineR). We compared our results with those of four recent studies using direct approaches. RESULTS: We evaluated a total of 81 sex- and age-specific reference intervals, for which at least 120 measurements were available. The overall agreement between indirectly and directly determined reference intervals was surprisingly good as nearly every fourth reference limit could be confirmed by narrow tolerance limits. Furthermore, lower reference limits could be provided for some low concentrated hormones by the indirect method. In cases of substantial deviations, our results matched the underlying data better than reference intervals from external studies. CONCLUSIONS: Our study shows for the first time that indirect methods are a valuable tool to verify existing reference intervals for steroid hormones. A simple "modified Hoffmann approach" based on the general assumption of a normal or lognormal distribution model is sufficient for screening purposes, while the refineR algorithm may be used for a more detailed analysis.


Subject(s)
Steroids , Tandem Mass Spectrometry , Humans , Tandem Mass Spectrometry/methods , Reference Values , Hormones , Age Factors
4.
J Assist Reprod Genet ; 39(12): 2689-2697, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36308613

ABSTRACT

The differentiation of endometrial stromal cells, named decidualization, is essential for the proper formation of the materno-fetal interphase. One important feature of decidualization is the increased glucose consumption and its utilization by endometrial cells to produce energy. Besides glucose, fatty acids are another important energy source for living cells and it has been described that endometrial stromal cells rely on the proper function of the oxidation of fatty acids for the correct decidualization. It is, however, unknown whether the turn-over of fatty acid degradation is modified during decidualization. Furthermore, it is also unknown how the final products of glucose and fatty acid catabolism are related to the function of the tricarboxylic acid cycle for the efficient ATP production. In this study, we evaluated the content levels of different intermediate metabolites and the expression of the key enzymes related to the degradation of glucose and fatty acids during the in vitro decidualization of human endometrial stromal cells. Our results suggest that human endometrial stromal cells undergo energetic metabolic changes during decidualization and that decidualizing and non-decidualizing cells differ in the level of activation of different metabolic pathways and, probably, in the use of intermediate metabolites.


Subject(s)
Endometrium , Glucose , Female , Humans , Glucose/metabolism , Endometrium/metabolism , Metabolic Networks and Pathways , Fatty Acids/metabolism , Stromal Cells , Cells, Cultured
5.
Amino Acids ; 51(6): 903-911, 2019 Jun.
Article in English | MEDLINE | ID: mdl-30941574

ABSTRACT

Donor preconditioning with glycine prevents Kupffer cell-dependent reperfusion injury to liver grafts. Partial liver grafts need to regenerate and grow in size after transplantation; however, glycine inactivates Kupffer cells, which are important for hepatic regeneration. Thus, this study was designed to evaluate the impact of donor preconditioning with glycine after partial liver transplantation (pLTx). PLTx was performed in 28 female Sprague-Dawley rats. Glycine (1.5 ml, 300 mM; i.v.) was given to 14 live donors before organ procurement. Liver enzymes and histology were investigated 8 h after reperfusion to index liver injury and leukocyte infiltration. Hepatic microperfusion and leukocyte-endothelium interaction were assessed using the in vivo fluorescence microscopy method. Ki-67 and TNF-α were detected by immunohistochemistry for regeneration and Kupffer cell activation. Glycine significantly increased survival from 0% in controls to 40%, while both liver enzyme levels and necrosis were decreased to about 50% of controls (p < 0.05). Sinusoidal blood flow increased by 40-80%, while leukocyte-endothelium interaction decreased to 30% of control values (p < 0.05). While Kupffer cell-derived TNF-α decreased to 70% of controls, there was no difference between groups in Ki-67 expression. Data presented here clearly demonstrate that glycine protects partial liver grafts from reperfusion injury without effects on regeneration.


Subject(s)
Glycine/pharmacology , Liver Regeneration/drug effects , Liver Transplantation/adverse effects , Protective Agents/pharmacology , Reperfusion Injury/prevention & control , Animals , Female , Ki-67 Antigen/analysis , Kupffer Cells/metabolism , Liver/metabolism , Liver Regeneration/physiology , Necrosis/prevention & control , Rats , Rats, Sprague-Dawley , Tumor Necrosis Factor-alpha/analysis
6.
Arch Gynecol Obstet ; 300(6): 1741-1750, 2019 12.
Article in English | MEDLINE | ID: mdl-31667611

ABSTRACT

PURPOSE: Implantation rates differ according to ovulation induction agents in ART. This study investigates the different local endometrial effects of LH- versus hCG-induced ovulation. METHODS: Endometrial stromal cells from healthy patients were cultured with hCG or LH in different concentrations, supplemented with 250 ng/mL hCG and progesterone after 2 and 5 days. In addition after decidualization induction, cells were treated with hCG (50 or 250 ng/mL) or LH (10 or 50 ng/mL) for 3 days. Receptivity markers expression was evaluated by real-time quantitative PCR on day 3 and 6. RESULTS: On day 3, non-decidualized cells treated with LH showed an increased expression of IGFBP1, IL-8 and CXCL12 compared to hCG. The expression pattern changed on day 6, where cells treated with hCG showed higher expression of implantation markers compared to LH-treated cells. Furthermore, on day 3, decidualized cells treated with hCG250 showed an increased IL8 and CXCL12 expression compared to LH10. CONCLUSIONS: LH seems to modulate the local endometrial expression of receptivity markers earlier compared to hCG; however, the effect is not sustained over time in cells without prior decidualization. Though, in decidualized cells, pattern changed and an earlier positive effect of hCG was shown on IL-8 and CXCL12.


Subject(s)
Chorionic Gonadotropin/pharmacology , Endometrium/metabolism , Luteinizing Hormone/pharmacology , Ovulation Induction/methods , Adult , Biomarkers/metabolism , Cells, Cultured , Chemokine CXCL12/genetics , Embryo Implantation/drug effects , Female , Humans , Interleukin-8/genetics
7.
NMR Biomed ; 31(6): e3926, 2018 06.
Article in English | MEDLINE | ID: mdl-29694688

ABSTRACT

Blood clotting is a fundamental biochemical process in post-hemorrhagic hemostasis. Although the varying appearance of coagulating blood in T1 - and T2 -weighted images is widely used to qualitatively determine bleeding age, the technique permits only a rough discrimination of coagulation stages, and it remains difficult to distinguish acute and chronic hemorrhagic stages because of low T1 - and T2 -weighted signal intensities in both instances. To investigate new biomedical parameters for magnetic resonance imaging-based characterization of blood clotting kinetics, sodium imaging and quantitative susceptibility mapping (QSM) were compared with conventional T1 - and T2 -weighted imaging, as well as with biochemical hemolysis parameters. For this purpose, a blood-filled spherical agar phantom was investigated daily for 14 days, as well as after 24 days at 7 T after initial preparation with fresh blood. T1 - and T2 -weighted sequences, a three-dimensional (3D) gradient echo sequence and a density-adapted 3D radial projection reconstruction pulse sequence for 23 Na imaging were applied. For hemolysis estimations, free hemoglobin and free potassium concentrations were measured photometrically and with the direct ion-selective electrode method, respectively, in separate heparinized whole-blood samples along the same timeline. Initial mean susceptibility was low (0.154 ± 0.020 ppm) and increased steadily during the course of coagulation to reach up to 0.570 ± 0.165 ppm. The highest total sodium (NaT) values (1.02 ± 0.06 arbitrary units) in the clot were observed initially, dropped to 0.69 ± 0.13 arbitrary units after one day and increased again to initial values. Compartmentalized sodium (NaS) showed a similar signal evolution, and the NaS/NaT ratio steadily increased over clot evolution. QSM depicts clot evolution in vitro as a process associated with hemoglobin accumulation and transformation, and enables the differentiation of the acute and chronic coagulation stages. Sodium imaging visualizes clotting independent of susceptibility and seems to correspond to clot integrity. A combination of QSM and sodium imaging may enhance the characterization of hemorrhage.


Subject(s)
Blood Coagulation/physiology , Imaging, Three-Dimensional , Sodium/chemistry , Adult , Hemoglobins/metabolism , Humans , Kinetics , Male , Phantoms, Imaging , Potassium/metabolism , Time Factors
8.
Eur Surg Res ; 59(1-2): 91-99, 2018.
Article in English | MEDLINE | ID: mdl-30032156

ABSTRACT

BACKGROUND: Experimental pneumoperitoneum induces ischemia/reperfusion injury (IRI) in the liver, most likely via Kupffer cell (KC)-dependent mechanisms. Glycine has been shown to ameliorate IRI in various animal models. Thus, this study was performed to assess the effects of glycine on the liver after pneumoperitoneum. MATERIALS AND METHODS: Sprague-Dawley rats (220-250 g in weight) underwent CO2 pneumoperitoneum (12 mm Hg) for 90 min. Some rats received i.v. glycine (1.5 mL, 300 mM) 10 min before pneumoperitoneum. Controls were given the same volume of Ringer's solution. Transaminases, hepatic microcirculation, and phagocytosis of latex beads indexing both liver injury and KC activation were examined following pneumoperitoneum. Analysis of variance (ANOVA), plus a subsequent t test or χ2 test (or Fisher's exact test) were carried out as appropriate. Results are presented as mean ± SEM. RESULTS: Glycine significantly decreased lactate dehydrogenase at 1 h and both aspartate aminotransferase and alanine aminotransferase at 2 h after pneumoperitoneum from 477 ± 43, 154 ± 17, and 60 ± 6 U/L in controls to 348 ± 25, 101 ± 11, and 34 ± 3 U/L, respectively (p < 0.05). In parallel, glycine significantly decreased both the rate of permanent adherence of leukocytes to the endothelium by up to 35% and the rate of phagocytosis by > 50% compared to the control group. CONCLUSION: Glycine decreased IRI after pneumoperitoneum, most likely via KC-dependent mechanisms.


Subject(s)
Glycine/pharmacology , Liver/blood supply , Pneumoperitoneum, Artificial/adverse effects , Reperfusion Injury/prevention & control , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Female , Kupffer Cells/physiology , Phagocytosis , Rats , Rats, Sprague-Dawley
9.
Haematologica ; 102(8): 1424-1431, 2017 08.
Article in English | MEDLINE | ID: mdl-28522573

ABSTRACT

Chemotherapy in light chain amyloidosis aims to normalize the involved free light chain in serum, which leads to an improvement, or at least stabilization of organ function in most responding patients. We performed a prospective single center phase 2 trial with 50 untreated patients not eligible for high-dose treatment. The treatment schedule comprised 6 cycles of oral lenalidomide, melphalan and dexamethasone every 4 weeks. After 6 months, complete remission was achieved in 9 patients (18%), very good partial remission in 16 (32%) and partial response in 9 (18%). Overall, organ response was observed in 24 patients (48%). Hematologic and cardiac toxicities were predominant adverse events. Mortality at 3 months was low at 4% (n=2) despite the inclusion of 36% of patients (n=18) with cardiac stage Mayo 3. After a median follow-up of 50 months, median overall and event-free survival were 67.5 months and 25.1 months, respectively. We conclude that the treatment of lenalidomide, melphalan and dexamethasone is very effective in achieving a hematologic remission, organ response and, consecutively, a long survival in transplant ineligible patients with light chain amyloidosis. However, as toxicity and tolerability are the major problems of a 3-drug regimen, a strict surveillance program is necessary and sufficient to avoid severe toxicities. clinicaltrials.gov Identifier: 00883623 (Eudract2008-001405-41).


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Immunoglobulin Light-chain Amyloidosis/drug therapy , Aged , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Dexamethasone , Female , Follow-Up Studies , Humans , Immunoglobulin Light-chain Amyloidosis/mortality , Lenalidomide , Male , Melphalan , Middle Aged , Remission Induction/methods , Survival Analysis , Thalidomide/analogs & derivatives
10.
Am J Physiol Heart Circ Physiol ; 311(3): H592-603, 2016 09 01.
Article in English | MEDLINE | ID: mdl-27342874

ABSTRACT

Pressure unloading represents the only effective therapy in increased afterload-induced left ventricular hypertrophy (LVH) as it leads to myocardial reverse remodeling (reduction of increased left ventricular mass, attenuated myocardial fibrosis) and preserved cardiac function. However, the effect of myocardial reverse remodeling on cardiac mechanoenergetics has not been elucidated. Therefore, we aimed to provide a detailed hemodynamic characterization in a rat model of LVH undergoing pressure unloading. Pressure overload was induced in Sprague-Dawley rats by abdominal aortic banding for 6 (AB 6th wk) or 12 wk (AB 12th wk). Sham-operated animals served as controls. Aortic debanding procedure was performed after the 6th experimental week (debanded 12th wk) to investigate the regression of LVH. Pressure unloading resulted in significant reduction of LVH (heart weight-to-tibial length ratio: 0.38 ± 0.01 vs. 0.58 ± 0.02 g/mm, cardiomyocyte diameter: 18.3 ± 0.1 vs. 24.1 ± 0.8 µm debanded 12th wk vs. AB 12th wk, P < 0.05), attenuated the extracellular matrix remodeling (Masson's score: 1.37 ± 0.13 vs. 1.73 ± 0.10, debanded 12th wk vs. AB 12th wk, P < 0.05), provided protection against the diastolic dysfunction, and reversed the maladaptive contractility augmentation (slope of end-systolic pressure-volume relationship: 1.39 ± 0.24 vs. 2.04 ± 0.09 mmHg/µl, P < 0.05 debanded 12th wk vs. AB 6th wk, P < 0.05). In addition, myocardial reverse remodeling was also associated with preserved ventriculoarterial coupling and increased mechanical efficiency (50.6 ± 2.8 vs. 38.9 ± 2.5%, debanded 12th wk vs. AB 12th wk, P < 0.05), indicating a complete functional and mechanoenergetic recovery. According to our best knowledge, this is the first study demonstrating that the regression of LVH is accompanied by maintained cardiac mechanoenergetics.


Subject(s)
Energy Metabolism , Hypertrophy, Left Ventricular/genetics , Myocardial Contraction , Myocardium/metabolism , Ventricular Remodeling , Animals , Aorta/surgery , Blotting, Western , Echocardiography , Fibrosis , Hemodynamics , Hypertrophy, Left Ventricular/diagnostic imaging , Hypertrophy, Left Ventricular/pathology , Hypertrophy, Left Ventricular/physiopathology , Male , Myocardium/pathology , Myocytes, Cardiac/pathology , Pressure , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction
11.
Am J Physiol Heart Circ Physiol ; 311(4): H958-H971, 2016 10 01.
Article in English | MEDLINE | ID: mdl-27521423

ABSTRACT

The Goto-Kakizaki (GK) rat, a non-obese model of type 2 diabetes mellitus (T2DM), was generated by the selective inbreeding of glucose-intolerant Wistar rats. This is a convenient model for studying diabetes-induced cardiomyopathy independently from the effects of the metabolic syndrome. We investigated the myocardial functional and structural changes and underlying molecular pathomechanisms of short-term and mild T2DM. The presence of DM was confirmed by an impaired oral glucose tolerance in the GK rats compared with the age-matched nondiabetic Wistar rats. Data from cardiac catheterization showed that in GK rats, although the systolic indexes were not altered, the diastolic stiffness was increased compared with nondiabetics (end-diastolic-pressure-volume-relationship: 0.12 ± 0.04 vs. 0.05 ± 0.01 mmHg/µl, P < 0.05). Additionally, DM was associated with left-ventricular hypertrophy and histological evidence of increased myocardial fibrosis. The plasma pro-B-type natriuretic peptide, the cardiac troponin-T, glucose, and the urinary glucose concentrations were significantly higher in GK rats. Among the 125 genes surveyed using PCR arrays, DM significantly altered the expression of five genes [upregulation of natriuretic peptide precursor-A and connective tissue growth factor, downregulation of c-reactive protein, interleukin-1ß, and tumor necrosis factor (TNF)-α mRNA-level]. Of the altered genes, which were evaluated by Western blot, only TNF-α protein expression was significantly decreased. The ECG recordings revealed no significant differences. In conclusion, while systolic dysfunction, myocardial inflammation, and abnormal electrical conduction remain absent, short-term and mild T2DM induce the alteration of cardiac TNF-α at both the mRNA and protein levels. Further assessments are required to reveal if TNF-α plays a role in the early stage of diabetic cardiomyopathy development.


Subject(s)
Diabetes Mellitus, Type 2/genetics , Hypertrophy, Left Ventricular/genetics , Myocardium/metabolism , Ventricular Dysfunction, Left/genetics , Ventricular Function, Left , Ventricular Pressure , Animals , Apoptosis/genetics , Atrial Natriuretic Factor/genetics , Blood Glucose/metabolism , C-Reactive Protein/genetics , Connective Tissue Growth Factor/genetics , Diabetes Mellitus, Type 2/pathology , Diabetes Mellitus, Type 2/physiopathology , Down-Regulation , Echocardiography , Electrocardiography , Fibrosis , Glucose Tolerance Test , Glycosuria , Hypertrophy, Left Ventricular/pathology , Hypertrophy, Left Ventricular/physiopathology , Immunohistochemistry , In Situ Nick-End Labeling , Inflammation/genetics , Interleukin-1beta/genetics , Male , Myocardium/pathology , Natriuretic Peptide, Brain/metabolism , Oxidative Stress/genetics , Peptide Fragments/metabolism , Polymerase Chain Reaction , RNA, Messenger/metabolism , Rats , Rats, Wistar , Signal Transduction , Troponin T/metabolism , Tumor Necrosis Factor-alpha/genetics , Tyrosine/analogs & derivatives , Tyrosine/metabolism , Up-Regulation , Ventricular Dysfunction, Left/pathology , Ventricular Dysfunction, Left/physiopathology
12.
Arch Gynecol Obstet ; 292(2): 465-72, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25687657

ABSTRACT

PURPOSE: To assess the metformin effect on endometrial stromal cell decidualization, proliferation, gene and protein expression of IGFBPs, IGFs and their receptors. METHODS: Human endometrial stromal cells (hESCs) were cultured from endometrial biopsies of 11 women undergoing surgery for benign reasons. hESCs were decidualized with and without metformin in increasing doses. Supernatant and cells were harvested after decidualization for 12-14 days, followed by real-time PCR of IGFBP 1-6, IGF I, IGF II and their receptors. Prolactin, and IGFBP-1, -3, and -6 were additionally analyzed in supernatant by ELISA. Proliferation of hESCs and decidualization of hESCs were assessed under the influence of metformin. Data were analyzed using the paired t test with p < 0.05 considered significant. RESULTS: While lower concentrations of metformin (10(-4), 10(-5 )M) did not influence the decidualization and proliferation capacity of hESCs, higher concentrations (10(-3), 10(-2 )M metformin) significantly (p < 0.05) diminished decidualization, as well as stromal cell proliferation in a dose-dependent manner. Higher concentrations of metformin lead to a significant (p < 0.05) dose-dependent attenuation of the progesterone effect with regard to IGFBP-1, -3, -5, -6, as well as IGF I receptor, while it did not change the expression of IGFBP-2 and -4, IGF I and II and the IGF II receptor. This was confirmed on the protein level for IGFBP-1, -3, and -6. CONCLUSION: We were able to demonstrate for the first time a dose-dependent local effect of metformin within hESCs. Metformin might therefore influence locally the endometrial proliferation and maturation, and could open up new treatment options for gynecological diseases by vaginal application of metformin.


Subject(s)
Embryo Implantation/drug effects , Endometrium/metabolism , Hypoglycemic Agents/pharmacology , Metformin/pharmacology , Stromal Cells/metabolism , Cells, Cultured , Dose-Response Relationship, Drug , Endometrium/drug effects , Epithelial Cells/metabolism , Female , Humans , Hypoglycemic Agents/administration & dosage , Insulin-Like Growth Factor Binding Protein 1/genetics , Insulin-Like Growth Factor Binding Protein 1/metabolism , Insulin-Like Growth Factor I/genetics , Insulin-Like Growth Factor I/metabolism , Insulin-Like Growth Factor II/genetics , Insulin-Like Growth Factor II/metabolism , Metformin/administration & dosage , Progesterone/pharmacology , Prolactin/genetics , Prolactin/metabolism , Receptor, IGF Type 1/genetics , Receptor, IGF Type 1/metabolism , Stromal Cells/drug effects
13.
Brain Behav Immun ; 41: 200-9, 2014 Oct.
Article in English | MEDLINE | ID: mdl-24886966

ABSTRACT

Infectious complications are the leading cause of death in the post-acute phase of stroke. Post-stroke immunodeficiency is believed to result from neurohormonal dysregulation of the sympathetic nervous system (SNS) and hypothalamic-pituitary-adrenal (HPA) axis. However, the differential effects of these neuroendocrine systems on the peripheral immune cells are only partially understood. Here, we determined the impact of the hormones of the SNS and HPA on distinct immune cell populations and characterized their interactions after stroke. At various time points after cortical or extensive hemispheric cerebral ischemia, plasma cortisone, corticosterone, metanephrine and adrenocorticotropic hormone (ACTH) levels were measured in mice. Leukocyte subpopulations were flow cytometrically analyzed in spleen and blood. To investigate their differential sensitivity to stress hormones, splenocytes were incubated in vitro with prednisolone, epinephrine and their respective receptor blockers. Glucocorticoid receptor (GCR) and beta2-adrenergic receptor (ß2-AR) on leukocyte subpopulations were quantified by flow cytometry. In vivo effects of GCR and selective ß2-AR blockade, respectively, were defined on serum hormone concentrations, lymphopenia and interferon-γ production after severe ischemia. We found elevated cortisone, corticosterone and metanephrine levels and associated lymphocytopenia only after extensive brain infarction. Prednisolone resulted in a 5 times higher cell death rate of splenocytes than epinephrine in vitro. Prednisolone and epinephrine-induced leukocyte cell death was prevented by GCR and ß2-AR blockade, respectively. In vivo, only GCR blockade prevented post ischemic lymphopenia whereas ß2-AR preserved interferon-γ secretion by lymphocytes. GCR blockade increased metanephrine levels in vivo and prednisolone, in turn, decreased ß2-AR expression on lymphocytes. In conclusion, mediators of the SNS and the HPA axis differentially affect the systemic immune system after stroke. Moreover, our findings suggest a negative-feedback of corticosteroids on the sympathetic axis which may control the post-stroke stress-reaction. This complex interplay between the HPA and the SNS after stroke has to be considered when targeting the neurohormonal systems in the post acute phase of severe stroke.


Subject(s)
Hypothalamo-Hypophyseal System/physiopathology , Infarction, Middle Cerebral Artery/immunology , Neuroimmunomodulation/physiology , Pituitary-Adrenal System/physiopathology , Sympathetic Nervous System/physiopathology , Animals , Apoptosis/drug effects , Cells, Cultured , Corticosterone/blood , Cortisone/blood , Epinephrine/pharmacology , Feedback, Physiological , Infarction, Middle Cerebral Artery/blood , Infarction, Middle Cerebral Artery/physiopathology , Interferon-gamma/biosynthesis , Leukocytes/cytology , Leukocytes/drug effects , Lymphopenia/etiology , Male , Metanephrine/blood , Mice , Mice, Inbred C57BL , Mifepristone/pharmacology , Neuroimmunomodulation/drug effects , Prednisolone/pharmacology , Propanolamines/pharmacology , Receptors, Adrenergic, beta-2/analysis , Receptors, Adrenergic, beta-2/biosynthesis , Receptors, Adrenergic, beta-2/drug effects , Receptors, Glucocorticoid/analysis , Receptors, Glucocorticoid/antagonists & inhibitors
14.
Eur Neurol ; 72(5-6): 278-84, 2014.
Article in English | MEDLINE | ID: mdl-25323105

ABSTRACT

BACKGROUND: In patients presenting with acute vertigo or dizziness, identifying the posterior fossa stroke as the underlying cause can be a major challenge. We therefore evaluated the serum biomarkers for the differential diagnosis of nonvascular vertigo and posterior circulation stroke. METHODS: Of a total of 80 patients, 31 patients had an ischemic stroke in the posterior circulation and 12 infratentorial hemorrhage. Findings in these patients were compared with those in 22 patients with vertigo of nonvascular origin and 15 matched control patients without neurological symptoms. Blood samples drawn <24 h after symptom onset were analyzed for S100 calcium-binding protein B (S100ß), matrix metalloproteinase 9 (MMP-9), soluble vascular cellular adhesion molecule-1 (sVCAM-1), and glial fibrillary acidic protein (GFAP). RESULTS/CONCLUSION: Serum levels of S100ß were significantly higher in stroke patients than in nonvascular vertigo patients. Serum concentrations of MMP-9 tended to be higher in stroke patients, whereas no significant differences among groups were found for sVCAM-1 and GFAP. Receiver-operating characteristic analysis revealed a sensitivity of 94.4% and a specificity of 31.8% for detecting stroke in patients presenting with vertigo for S100ß. S100ß may serve as a biomarker for distinguishing between vertigo of vascular causes and nonvascular, acute vertigo.


Subject(s)
S100 Calcium Binding Protein beta Subunit/blood , Stroke/blood , Vertigo/blood , Aged , Area Under Curve , Biomarkers/blood , Brain Ischemia/blood , Brain Ischemia/diagnosis , Diagnosis, Differential , Female , Glial Fibrillary Acidic Protein/blood , Humans , Male , Matrix Metalloproteinase 9/blood , Middle Aged , Pilot Projects , Prospective Studies , ROC Curve , Sensitivity and Specificity , Stroke/complications , Stroke/diagnosis , Vascular Cell Adhesion Molecule-1/blood , Vertigo/diagnosis , Vertigo/etiology
15.
Stroke ; 44(3): 771-8, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23339956

ABSTRACT

BACKGROUND AND PURPOSE: Rivaroxaban has recently been approved for stroke prevention in atrial fibrillation. However, lack of an effective antidote represents a major concern in the event of intracerebral hemorrhage (ICH). The aims of the present study were to establish a murine model of ICH associated with rivaroxaban, and to examine the effectiveness of different hemostatic factors in preventing excess hematoma expansion. METHODS: In C57BL/6 mice receiving 10 or 30 mg/kg rivaroxaban by gastric gavage, plasma concentration, prothrombin time, and coagulation factor activities were measured repeatedly. Thirty minutes after inducing ICH by intrastriatal collagenase-injection, mice received an intravenous injection of either saline, prothrombin complex concentrate (100 U/kg), murine fresh frozen plasma (200 µL), or recombinant human Factor VIIa (1 mg/kg). ICH volume was quantified on brain cryosections and using hemoglobin spectrophotometry 24 hours later. RESULTS: Rivaroxaban in 30 mg/kg dose substantially increased the hematoma volume in ICH induced by 0.060 U collagenase. Prothrombin complex concentrate, fresh frozen plasma, or Factor VIIa prevented excess hematoma expansion caused by anticoagulation. Prevention of hematoma expansion by prothrombin complex concentrate was dose-dependent. None of the 3 agents completely corrected the prolonged prothrombin time, although they restored the activities of deficient FII and X. CONCLUSIONS: Prothrombin complex concentrate, Factor VIIa, and fresh frozen plasma prevent excess intracerebral hematoma expansion in a murine ICH model associated with rivaroxaban. The efficacy and safety of this reversal strategy must be further evaluated in clinical studies.


Subject(s)
Anticoagulants/adverse effects , Cerebral Hemorrhage/chemically induced , Cerebral Hemorrhage/drug therapy , Hemostatic Techniques , Morpholines/adverse effects , Thiophenes/adverse effects , Animals , Blood Coagulation Factors/adverse effects , Blood Coagulation Factors/therapeutic use , Dose-Response Relationship, Drug , Factor VIIa/adverse effects , Factor VIIa/therapeutic use , Hematoma/prevention & control , Male , Mice , Mice, Inbred C57BL , Models, Animal , Plasma , Rivaroxaban , Treatment Outcome
16.
J Clin Microbiol ; 51(6): 1906-8, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23515539

ABSTRACT

We evaluated the fully automated molecular BD MAX Cdiff assay (BD Diagnostics) and the Xpert C. difficile test (Cepheid) for rapid detection of Clostridium difficile infection. Culture was done on chromogenic agar followed by matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry identification and toxin detection. Repeat testing was required for 1.8% and 6.0% of the BD MAX and Xpert tests, respectively. Sensitivities, specificities, positive predictive values (PPV), and negative predictive values (NPV) were 90.5%, 97.9%, 89.3%, and 98.1%, respectively, for BD MAX and 97.3%, 97.9%, 90.0%, and 99.5%, respectively, for Xpert.


Subject(s)
Bacteriological Techniques/methods , Clostridioides difficile/isolation & purification , Clostridium Infections/diagnosis , Clostridium Infections/microbiology , Feces/microbiology , Molecular Diagnostic Techniques/methods , Automation, Laboratory/methods , Bacterial Toxins/analysis , Chromogenic Compounds/metabolism , Clostridioides difficile/chemistry , Clostridioides difficile/genetics , Culture Media/chemistry , Humans , Predictive Value of Tests , Sensitivity and Specificity , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization/methods
17.
Blood ; 116(4): 522-8, 2010 Jul 29.
Article in English | MEDLINE | ID: mdl-20375312

ABSTRACT

Treatment with oral melphalan and dexamethasone (M-Dex) was reported to be effective and feasible in patients with systemic light chain amyloidosis (AL) not eligible for high-dose melphalan. We report on 61 patients with advanced AL who were treated with intravenous M-Dex as first-line therapy. Estimated median overall survival (OS) was 17.5 months. Seventeen patients (28%) died within 3 months, mostly of disease-related complications. In addition, nonhematologic toxicity of Common Terminology Criteria grade 3 or 4 was observed in 20 patients, whereas hematologic toxicity was low. Twenty-seven patients (44%) had hematologic response, including complete in 7 patients (11%) and partial remission in 20 patients (33%). Organ response was observed in 15 patients (25%). The amount of the involved free light chains in serum and Karnofsky Index at diagnosis significantly influenced OS. Plasma levels of the cardiac biomarkers before start of treatment and their increase after the third M-Dex cycle also were strong negative predictors of OS. These parameters might help to identify patients who will not benefit from M-Dex chemotherapy.


Subject(s)
Amyloidosis/diagnosis , Amyloidosis/drug therapy , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Dexamethasone/administration & dosage , Heart Diseases/drug therapy , Melphalan/administration & dosage , Adult , Aged , Amyloidosis/complications , Amyloidosis/mortality , Female , Heart Diseases/complications , Heart Diseases/mortality , Heart Diseases/pathology , Humans , Immunoglobulin Light Chains/metabolism , Injections, Intravenous , Lymphoproliferative Disorders/complications , Lymphoproliferative Disorders/drug therapy , Lymphoproliferative Disorders/mortality , Male , Middle Aged , Prognosis , Retrospective Studies , Severity of Illness Index , Survival Analysis
18.
Langenbecks Arch Surg ; 397(8): 1323-31, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23111581

ABSTRACT

BACKGROUND: Ischemia/reperfusion injury is an obstacle especially in steatotic livers, including those with steatosis induced by acute toxic stress. Recently, a modified histidine-tryptophan-ketoglutarate (HTK) solution, HTK-N, has been developed. This solution contains N-acetylhistidine, amino acids, and iron chelators. This study was designed to test the effects of HTK-N on preservation injury to rat livers after acute toxic injury. METHODS: Microvesicular steatosis was induced by a single dose of ethanol (8 g/kg BW). Livers were harvested and stored at 4 °C for 8 h with HTK or HTK-N before transplantation. Tissue and blood samples were taken at 1, 8, and 24 h after reperfusion to compare serum liver enzymes (aspartate aminotransferase, alanine aminotransferase, and lactate dehydrogenase), standard histology, and immunohistochemistry for myeloperoxidase (MPO), caspase-3, and inducible nitric oxide synthase. Survival was compared after 1 week. For statistics, Analysis of Variance and t test were used. RESULTS: HTK-N improved survival from 12.5% in HTK to 87.5% (p < 0.05). Furthermore, liver enzymes were decreased to 2-75% of HTK values (p < 0.05). Necrosis and leukocyte infiltration and MPO, caspase-3, and iNOS expression after transplantation were decreased (p < 0.05). CONCLUSIONS: This study demonstrates that HTK-N protects liver grafts with microvesicular steatosis caused by acute toxic injury from cold ischemic injury better than standard HTK most likely via inhibition of hypoxic injury and oxidative stress and amelioration of the inflammatory reaction occurring upon reperfusion.


Subject(s)
Fatty Liver/pathology , Histidine/analogs & derivatives , Liver Transplantation , Organ Preservation Solutions , Alanine Transaminase/blood , Animals , Aspartate Aminotransferases/blood , Cold Temperature , Ethanol/toxicity , Fatty Liver/surgery , Female , Glucose/chemistry , Histidine/analysis , Iron Chelating Agents , L-Lactate Dehydrogenase/blood , Liver/blood supply , Liver/pathology , Liver Transplantation/mortality , Liver Transplantation/pathology , Mannitol/chemistry , Microvessels/drug effects , Microvessels/pathology , Potassium Chloride/chemistry , Procaine/chemistry , Rats , Rats, Sprague-Dawley , Survival Rate
19.
Stroke ; 42(12): 3524-9, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21960573

ABSTRACT

BACKGROUND AND PURPOSE: Thrombolysis is the only approved therapy for ischemic stroke, but secondary hemorrhage is a severe complication. Because oral anticoagulants are believed to increase the risk of hemorrhage, thrombolysis is usually contraindicated in patients on vitamin K antagonists. We studied whether thrombolysis in a thromboembolic middle cerebral artery occlusion model in rats pretreated with warfarin increases secondary hemorrhage, and whether substitution of coagulation factors before thrombolysis prevents hemorrhagic complications. METHODS: Wistar rats were anticoagulated using warfarin in drinking water (0.4 mg/kg per 24 hours). Strength of anticoagulation was monitored using benchside international normalized ratio (INR) coagulometry. Two hours after middle cerebral artery occlusion, recombinant tissue-type plasminogen activator (9 mg/kg) was administered. Two of 5 groups of animals received prothrombin complex concentrate (PCC, 50 U/kg) 15 minutes before thrombolysis. Serial magnetic resonance imaging was performed 20 minutes, 2.5 hours, and 24 hours after middle cerebral artery occlusion. Secondary hemorrhage was quantified on T2* magnetic resonance images as previously established. RESULTS: Severity of hypoperfusion on initial perfusion-weighted imaging -magnetic resonance did not differ among groups. Thrombolysis resulted in successful reperfusion in all groups. Anticoagulated animals had significantly more secondary hemorrhage and a higher mortality rate compared with nonanticoagulated animals. PCC rapidly reversed the increased international normalized ratio. Although PCC failed to prevent hemorrhage in the strongly anticoagulated, it reduced the incidence of severe hemorrhage in moderately anticoagulated rats (INR, 2-3) to the level of nonanticoagulated controls. CONCLUSIONS: Preceding anticoagulation increases risk and extent of secondary hemorrhage after thrombolysis. Reversal of moderate anticoagulation using PCC may allow thrombolytic therapy without increasing the risk of secondary hemorrhage.


Subject(s)
Fibrinolytic Agents/therapeutic use , Hemorrhage/prevention & control , Thromboembolism/drug therapy , Tissue Plasminogen Activator/therapeutic use , Warfarin/therapeutic use , Animals , Blood Coagulation/drug effects , Fibrinolytic Agents/pharmacology , Hemorrhage/complications , Male , Rats , Rats, Wistar , Thromboembolism/complications , Tissue Plasminogen Activator/pharmacology , Warfarin/pharmacology
20.
Stroke ; 42(12): 3594-9, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21998060

ABSTRACT

BACKGROUND AND PURPOSE: Dabigatran-etexilate (DE) recently has been approved for stroke prevention in atrial fibrillation. However, lack of effective antagonists represents a major concern in the event of intracerebral hemorrhage (ICH). The aims of the present study were to establish a murine model of ICH associated with dabigatran, and to test the efficacy of different hemostatic factors in preventing hematoma growth. METHODS: In C57BL/6 mice receiving DE (4.5 or 9.0 mg/kg), in vivo and in vitro coagulation assays and dabigatran plasma levels were measured repeatedly. Thirty minutes after inducing ICH by striatal collagenase injection, mice received an intravenous injection of saline, prothrombin complex concentrate (PCC; 100 U/kg), murine fresh-frozen plasma (200 µL), or recombinant human factor VIIa (8.0 mg/kg). ICH volume was quantified on brain cryosections 24 hours later. RESULTS: DE substantially prolonged tail vein bleeding time and ecarin clotting time for 4 hours corresponding to dabigatran plasma levels. Intracerebral hematoma expansion was observed mainly during the first 3 hours on serial T2* MRI. Anticoagulation with high doses of DE increased the hematoma volume significantly. PCC and, less consistently, fresh-frozen plasma prevented excess hematoma expansion caused by DE, whereas recombinant human factor VIIa was ineffective. Prevention of hematoma growth and reversal of tail vein bleeding time by PCC were dose-dependent. CONCLUSIONS: The study provides strong evidence that PCC and, less consistently, fresh-frozen plasma prevent excess intracerebral hematoma expansion in a murine ICH model associated with dabigatran. The efficacy and safety of this strategy must be further evaluated in clinical studies.


Subject(s)
Antithrombins/therapeutic use , Benzimidazoles/therapeutic use , Brain/drug effects , Cerebral Hemorrhage/drug therapy , beta-Alanine/analogs & derivatives , Animals , Antithrombins/administration & dosage , Benzimidazoles/administration & dosage , Blood Coagulation/drug effects , Brain/pathology , Cerebral Hemorrhage/pathology , Dabigatran , Dose-Response Relationship, Drug , Mice , beta-Alanine/administration & dosage , beta-Alanine/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL